147 related articles for article (PubMed ID: 1978844)
1. Stress-related mucosal damage: review of drug therapy.
Vorder Bruegge WF; Peura DA
J Clin Gastroenterol; 1990; 12 Suppl 2():S35-40. PubMed ID: 1978844
[TBL] [Abstract][Full Text] [Related]
2. Stress-related mucosal damage.
Peura DA
Clin Ther; 1986; 8 Suppl A():14-23. PubMed ID: 2878727
[TBL] [Abstract][Full Text] [Related]
3. Achieving pH control in the critically ill patient: the role of continuous infusion of H2-receptor antagonists.
Moore JG
DICP; 1990 Nov; 24(11 Suppl):S28-30. PubMed ID: 1980180
[TBL] [Abstract][Full Text] [Related]
4. Stress-related mucosal disease in the intensive care unit: an update on prophylaxis.
Sesler JM
AACN Adv Crit Care; 2007; 18(2):119-26; quiz 127-8. PubMed ID: 17473539
[TBL] [Abstract][Full Text] [Related]
5. Indications for the use of parenteral H2-receptor antagonists.
Thompson JC; Walker JP
Am J Med; 1984 Nov; 77(5B):111-5. PubMed ID: 6150638
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of stress ulcers in critically ill patients.
Yang YX; Lewis JD
Semin Gastrointest Dis; 2003 Jan; 14(1):11-9. PubMed ID: 12610850
[TBL] [Abstract][Full Text] [Related]
7. Stress ulcer.
Klamut MJ; Keshavarzian A
J Assoc Acad Minor Phys; 1992; 3(3):89-94. PubMed ID: 1498526
[TBL] [Abstract][Full Text] [Related]
8. When should stress ulcer prophylaxis be used in the ICU?
Quenot JP; Thiery N; Barbar S
Curr Opin Crit Care; 2009 Apr; 15(2):139-43. PubMed ID: 19578324
[TBL] [Abstract][Full Text] [Related]
9. [Drug prevention and therapy of acute gastroduodenal lesions (stress ulcers)].
von Ritter C
Wien Med Wochenschr; 1992; 142(8-9):180-2. PubMed ID: 1354910
[TBL] [Abstract][Full Text] [Related]
10. A review of stress-related mucosal disease.
Monnig AA; Prittie JE
J Vet Emerg Crit Care (San Antonio); 2011 Oct; 21(5):484-95. PubMed ID: 22316196
[TBL] [Abstract][Full Text] [Related]
11. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
12. Stress-related mucosal disease: risk factors and prophylactic therapy.
Spirt MJ
Clin Ther; 2004 Feb; 26(2):197-213. PubMed ID: 15038943
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of parenteral histamine (H2)-antagonists in acid suppression for the prevention of stress ulceration.
Critchlow JF
Am J Med; 1987 Dec; 83(6A):23-8. PubMed ID: 2892406
[TBL] [Abstract][Full Text] [Related]
14. A dosage alternative for H2-receptor antagonists--constant infusion.
Siepler JK
Clin Ther; 1986; 8 Suppl A():24-33. PubMed ID: 2878728
[TBL] [Abstract][Full Text] [Related]
15. Stress-related mucosal bleeding in critically ill oncology patients.
Bruno JJ; Canada TW; Wakefield CD; Nates JL
J Oncol Pharm Pract; 2009 Mar; 15(1):9-16. PubMed ID: 18753185
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors for the prevention of stress-related mucosal disease in critically-ill patients: a meta-analysis.
Pongprasobchai S; Kridkratoke S; Nopmaneejumruslers C
J Med Assoc Thai; 2009 May; 92(5):632-7. PubMed ID: 19459523
[TBL] [Abstract][Full Text] [Related]
17. [Stress ulcerations: pathogenesis and prevention].
Holtermüller KH; Ebener B; Kühl HJ; Rolfs A
Z Gastroenterol; 1983 Mar; 21 Suppl():88-100. PubMed ID: 6134406
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis, diagnosis and treatment of acute gastric mucosal lesions.
Marrone GC; Silen W
Clin Gastroenterol; 1984 May; 13(2):635-50. PubMed ID: 6430609
[TBL] [Abstract][Full Text] [Related]
19. Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness.
Brett S
Crit Care; 2005 Feb; 9(1):45-50. PubMed ID: 15693983
[TBL] [Abstract][Full Text] [Related]
20. Stress ulceration: a serious complication in critically ill patients.
Konopad E; Noseworthy T
Heart Lung; 1988 Jul; 17(4):339-47. PubMed ID: 3292462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
